Is This Experimental Drug the New Mounjaro? Why It's Too Early To Tell

Viking Therapeutics released results from a phase 2 clinical trial for its experimental weight loss drug. People who received weekly injections of the drug lost up to 14.7% of their body weight over 13 weeks, researchers found.

March 4, 2024 Today's top story Is This Experimental Drug the New Mounjaro? Why It's Too Early To Tell Viking Therapeutics released results from a phase 2 clinical trial for its experimental weight loss drug. People who received weekly injections of the drug lost up to 14.7% of their body weight over 13 weeks, researchers found. Read on       'Reacher' Star Alan Ritchson Shares How He Manages Living with Bipolar Disorder Read ON   Eating Ultra-Processed Foods Linked to 32 Health Issues Like Heart Disease Read ON   CDC Tells Physicians to Conserve Tetanus Shots, Warns of Upcoming Shortage Read ON   More top Reads       Advertisement Healthy meal prep, simplified with Green Chef Menu variety for plant-powered choices, balanced living, keto, and paleo diets. GET STARTED

View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy  |  Unsubscribe Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Healthline is owned by RVO Health. © 2024 Healthline Media LLC 275 7th Ave., 24th Floor New York, NY 10001